Skip to Content

Self-Healing Plastic

A material repairs itself multiple times.
August 15, 2007

A new polymer material that fixes its own cracks could be a step toward self-healing medi­cal implants or self-­repairing materials for use in airplanes and spacecraft. It consists of an epoxy polymer layer containing tiny catalyst particles, deposited on a substrate containing microchannels filled with a liquid.

Self-repair: Cracks release fluid from ¬microchannels (tubes); the fluid solidifies after touch¬ing catalysts (dots).

When a crack in the polymer layer spreads to the micro­channels, the liquid flows out and comes in contact with the catalyst, says Nancy Sottos, a professor of materials science and engineering at the University of Illinois at Urbana-­Champaign and one of the researchers who led the work. Ten hours later, the liquid ­solidifies into a polymer.

Researchers have previously made self-healing plastics, but this is the first time anyone has made a material that can repair itself multiple times on its own. The material survived up to seven cracks before the catalyst stopped working.

“It’s essentially like giving life to a plastic,” says Chris Bielawski, a chemistry professor at the University of Texas at Austin. “This is an amazing proof of concept.”

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.